Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Other Receivables Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Other Receivables
€31.5m
CAGR 3-Years
40%
CAGR 5-Years
65%
CAGR 10-Years
51%
Genmab A/S
CSE:GMAB
Other Receivables
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Other Receivables
kr10.7m
CAGR 3-Years
-34%
CAGR 5-Years
-6%
CAGR 10-Years
1%
B
Bavarian Nordic A/S
CSE:BAVA
Other Receivables
kr29.6m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
10%
F
Fluoguide AS
STO:FLUO
Other Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Other Receivables
kr8.9m
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Ascendis Pharma A/S's Other Receivables?
Other Receivables
31.5m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Other Receivables amounts to 31.5m EUR.

What is Ascendis Pharma A/S's Other Receivables growth rate?
Other Receivables CAGR 10Y
51%

Over the last year, the Other Receivables growth was 103%. The average annual Other Receivables growth rates for Ascendis Pharma A/S have been 40% over the past three years , 65% over the past five years , and 51% over the past ten years .

Back to Top